Telix Pharmaceuticals Ltd. (TLX)
9.265
+0.24
(+2.60%)
USD |
NASDAQ |
Oct 28, 16:00
9.265
0.00 (0.00%)
After-Hours: 20:00
Telix Pharmaceuticals Price : 9.265 for Oct. 28, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 27, 2026 | 8.94 | 9.06 | 8.91 | 9.03 | 224848.0 |
| Oct 26, 2026 | 9.00 | 9.01 | 8.91 | 8.99 | 323417.0 |
| Oct 23, 2026 | 9.26 | 9.295 | 9.11 | 9.15 | 413442.0 |
| Oct 22, 2026 | 9.56 | 9.605 | 9.43 | 9.54 | 734054.0 |
| Oct 21, 2026 | 10.25 | 10.25 | 9.92 | 10.03 | 879078.0 |
| Oct 20, 2026 | 10.98 | 11.24 | 10.98 | 11.16 | 304952.0 |
| Oct 19, 2026 | 10.71 | 10.85 | 10.68 | 10.74 | 249790.0 |
| Oct 16, 2026 | 10.92 | 10.94 | 10.66 | 10.69 | 324859.0 |
| Oct 15, 2026 | 10.52 | 10.59 | 10.43 | 10.57 | 220693.0 |
| Oct 14, 2026 | 10.71 | 10.77 | 10.61 | 10.65 | 223277.0 |
| Oct 13, 2026 | 11.01 | 11.01 | 10.86 | 10.92 | 350808.0 |
| Oct 12, 2026 | 11.30 | 11.38 | 11.28 | 11.29 | 266214.0 |
| Oct 09, 2026 | 11.11 | 11.26 | 11.08 | 11.21 | 313023.0 |
| Oct 08, 2026 | 11.08 | 11.10 | 10.93 | 11.01 | 390349.0 |
| Oct 07, 2026 | 11.01 | 11.14 | 11.00 | 11.12 | 817437.0 |
| Oct 06, 2026 | 10.96 | 10.96 | 10.73 | 10.78 | 235101.0 |
| Oct 05, 2026 | 10.80 | 10.91 | 10.79 | 10.88 | 235286.0 |
| Oct 02, 2026 | 10.64 | 10.64 | 10.45 | 10.55 | 299612.0 |
| Oct 01, 2026 | 10.90 | 10.94 | 10.72 | 10.72 | 201808.0 |
| Sep 30, 2026 | 11.23 | 11.23 | 10.93 | 10.97 | 344245.0 |
| Sep 29, 2026 | 11.64 | 11.64 | 11.23 | 11.34 | 428308.0 |
| Sep 28, 2026 | 11.44 | 11.69 | 11.35 | 11.62 | 851000.0 |
| Sep 25, 2026 | 11.30 | 11.45 | 11.28 | 11.45 | 409202.0 |
| Sep 24, 2026 | 11.29 | 11.38 | 11.11 | 11.31 | 830287.0 |
| Sep 23, 2026 | 11.41 | 11.45 | 11.20 | 11.27 | 464894.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Mesoblast Ltd. | 13.38 |
| Immutep Ltd. | 3.30 |
| CSL Ltd. | 34.64 |
| Ceryvyn Therapeutics Ltd. | 0.0231 |
| Propanc Biopharma, Inc. | 2.10 |
Price Related Metrics
| PE Ratio | 99.09 |
| PS Ratio | 3.608 |
| Price to Book Value | 26.19 |
| Earnings Yield | 1.01% |
| Market Cap | 3.148B |
| Normalized PE Ratio | 169.69 |